Implementing Enterprise RPM: Takeaways from our Webinar with Baptist Health
Continuous glucose, the 5th vital sign, now available as part of Current Health. Learn more about our partnership with Dexcom.

Blog

Blog

Dartford and Gravesham NHS Home Health and Current partner to reduce hospital readmissions and emergency department visits

In times of increasingly strained resources for healthcare providers, institutions need to use all means necessary to make care more efficient, improve patient outcomes and reduce the stress of its staff....

Read more
Wireless wearable vital signs monitoring
Blog

Current Health receives FDA clearance for its remote patient monitoring solution, enabling earlier intervention and improved patient outcomes

New York and Edinburgh, Scotland, February 6, 2019 —Current Health, an artificial intelligence (AI)- powered wearable, today announced it has received Class II clearance from the U.S. Food and Drug...

Read more
Blog

IoT and patient-centered transformation: IoT evolution health conference preview

Telehealth and remote patient monitoring (RPM) are already enabling the creation of new healthcare models, with most medical aftercare delivered in patients’ homes, where they are most comfortable. But...

Read more
Blog

Putting AI to work in healthcare: turning data into actions

There’s no shortage of statistics, surveys and industry hype that have espoused the benefits of artificial intelligence (AI) within healthcare. AI already plays a significant role in our daily lives....

Read more
Blog

Have you heard? We’re now called Current Health. Keeping people healthy through wireless monitoring and personalized medicine

One of the questions I am most often asked is “why is it called snap40.” Here is the truth – it means nothing. As we’ve grown, it’s become important to start thinking about who we are and...

Read more
Blog

What FDA clearance and our work with Mount Sinai means for proactive healthcare

Today’s a big day at Current, which is saying a lot considering the year we’ve had. Today, we’re announcing that we’ve received Class II clearance from the U.S. Food and Drug Administration (FDA)...

Read more
1 2 4 5